Precigen, Inc. (PGEN) stock
PGENNasdaqPharmaceutical PreparationsFiscal year ends December 31
$4.27−0.02 (-0.47%)
Close on Nov 18, 2026Market cap $1.53BP/E –Yield –
Precigen revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
Precigen's revenue for the twelve months ending Jun 30, 2023 was $22.10M, up 43.1% year over year. For fiscal 2025 it was $9.68M, up 146.7% from the year before. Over ten years it grew -25.1% a year on average. The highest annual figure on record is $219.46M in fiscal 2017.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $9.68M | +146.7% |
| FY2024 | Dec 31, 2024 | $3.93M | -36.9% |
| FY2023 | Dec 31, 2023 | $6.23M | -76.9% |
| FY2022 | Dec 31, 2022 | $26.91M | +88.6% |
| FY2021 | Dec 31, 2021 | $14.27M | -55.4% |
| FY2020 | Dec 31, 2020 | $31.99M | -64.7% |
| FY2019 | Dec 31, 2019 | $90.72M | -40.0% |
| FY2018 | Dec 31, 2018 | $151.18M | -31.1% |
| FY2017 | Dec 31, 2017 | $219.46M | +14.9% |
| FY2016 | Dec 31, 2016 | $190.93M | +10.0% |
| FY2015 | Dec 31, 2015 | $173.61M | +141.4% |
| FY2014 | Dec 31, 2014 | $71.93M | +202.7% |
| FY2013 | Dec 31, 2013 | $23.76M | +72.5% |
| FY2012 | Dec 31, 2012 | $13.77M | +71.9% |
| FY2011 | Dec 31, 2011 | $8.01M | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $54.98M | +3011.4% |
| Q1 FY2026 | Mar 31, 2026 | $23.25M | +1156.2% |
| Q2 FY2025 | Jun 30, 2025 | $856.00K | -51.4% |
| Q1 FY2025 | Mar 31, 2025 | $1.34M | -92.0% |
| Q2 FY2023 | Jun 30, 2023 | $1.77M | -39.3% |
| Q1 FY2023 | Mar 31, 2023 | $1.85M | -66.4% |
| Q4 FY2022 | Dec 31, 2022 | $1.76M | -52.1% |
| Q3 FY2022 | Sep 30, 2022 | $16.72M | +401.7% |
| Q2 FY2022 | Jun 30, 2022 | $2.91M | -23.7% |
| Q1 FY2022 | Mar 31, 2022 | $5.51M | -77.5% |
| Q4 FY2021 | Dec 31, 2021 | $3.68M | -80.9% |
| Q3 FY2021 | Sep 30, 2021 | $3.33M | -85.9% |
| Q2 FY2021 | Jun 30, 2021 | $3.82M | -87.5% |
| Q1 FY2021 | Mar 31, 2021 | $24.51M | -17.9% |
| Q4 FY2020 | Dec 31, 2020 | $19.33M | +13.7% |
| Q3 FY2020 | Sep 30, 2020 | $23.58M | +28.9% |
| Q2 FY2020 | Jun 30, 2020 | $30.42M | -7.3% |
| Q1 FY2020 | Mar 31, 2020 | $29.84M | +32.1% |
| Q4 FY2019 | Dec 31, 2019 | $17.00M | -58.7% |
| Q3 FY2019 | Sep 30, 2019 | $18.30M | -39.1% |
| Q2 FY2019 | Jun 30, 2019 | $32.84M | -23.2% |
| Q1 FY2019 | Mar 31, 2019 | $22.59M | -39.2% |
| Q4 FY2018 | Dec 31, 2018 | $41.19M | -46.5% |
| Q3 FY2018 | Sep 30, 2018 | $30.06M | -34.7% |
| Q2 FY2018 | Jun 30, 2018 | $42.77M | -21.4% |
| Q1 FY2018 | Mar 31, 2018 | $37.16M | -30.5% |
| Q4 FY2017 | Dec 31, 2017 | $77.03M | +67.4% |
| Q3 FY2017 | Sep 30, 2017 | $46.02M | -6.1% |
| Q2 FY2017 | Jun 30, 2017 | $54.43M | – |
| Q1 FY2017 | Mar 31, 2017 | $53.50M | – |
| Q4 FY2016 | Dec 31, 2016 | $46.00M | – |
| Q3 FY2016 | Sep 30, 2016 | $48.99M | – |
See a number that looks wrong?